According to BridgeBio Pharma 's latest financial reports the company's total liabilities are $1.88 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $1.88 B | 1.12% |
2022-12-31 | $1.86 B | -0.55% |
2021-12-31 | $1.87 B | 215.32% |
2020-12-31 | $0.59 B | 282.59% |
2019-12-31 | $0.15 B | 77.79% |
2018-12-31 | $87.57 M | -42.66% |
2017-12-31 | $0.15 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $0.62 B | -67.05% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $12.01 M | -99.36% | ๐บ๐ธ USA |